data_2ruf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ruf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE2' HD13 ' A' ' 30' ' ' ILE . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.449 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 62' ' ' ARG . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.409 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' ND2' ' A' ' 115' ' ' ASN . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.408 ' ND2' HG23 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' OE1' ' CD1' ' A' ' 47' ' ' TYR . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.407 ' CD1' ' OE1' ' A' ' 31' ' ' GLU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' HD23 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 82' ' ' PHE . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.578 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 118' ' ' TYR . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.842 0.354 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' CD1' ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.53 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.432 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.436 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.407 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.5 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.588 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 29' ' ' LEU . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.824 0.345 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 17' ' ' TYR . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' PHE . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 96' ' ' PRO . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' A' ' 99' ' ' TYR . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 109' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.877 0.37 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 17' ' ' TYR . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 17' ' ' TYR . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.454 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 32' ' ' PHE . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' CG1' ' CE2' ' A' ' 111' ' ' PHE . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.411 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.888 0.375 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' TYR . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG21 HD12 ' A' ' 65' ' ' ILE . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.604 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 ' CE2' ' A' ' 32' ' ' PHE . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.603 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.4 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.352 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 32' ' ' PHE . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HG22 ' A' ' 65' ' ' ILE . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.404 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 99' ' ' TYR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.452 ' OD1' ' HG ' ' A' ' 87' ' ' LEU . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 115' ' ' ASN . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.902 0.382 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 32' ' ' PHE . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 41' ' ' LYS . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 67' ' ' LYS . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 65' ' ' ILE . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 47' ' ' TYR . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.3 p30 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.613 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' TYR . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 13' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' CD2' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.476 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.46 ' CE2' ' CG ' ' A' ' 31' ' ' GLU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' SER . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.415 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' CD2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 99' ' ' TYR . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.38 -43.01 57.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.9 tt -113.12 101.37 9.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.6 5.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.48 -163.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.42 131.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.57 49.1 80.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.713 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 96.5 Cg_endo -79.25 -41.42 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.528 2.152 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.98 160.44 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.148 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE2' HD13 ' A' ' 30' ' ' ILE . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG12 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.449 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 62' ' ' ARG . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 32' ' ' PHE . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.409 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' ND2' ' A' ' 115' ' ' ASN . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.408 ' ND2' HG23 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.19 115.54 4.2 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.573 2.182 . . . . 0.0 112.315 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mt -169.55 -63.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.97 -84.15 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.5 m -143.0 76.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 30.25 7.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.5 55.13 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.68 -47.1 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 0.0 112.299 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.35 151.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HD2' ' A' ' 76' ' ' PRO . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' OE1' ' CD1' ' A' ' 47' ' ' TYR . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.407 ' CD1' ' OE1' ' A' ' 31' ' ' GLU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' HD23 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 82' ' ' PHE . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.578 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 118' ' ' TYR . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.44 -171.89 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.47 2.113 . . . . 0.0 112.252 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -116.03 -14.99 11.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.334 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.73 48.6 0.62 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.584 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.7 m -82.75 80.5 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.27 -77.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.02 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.88 61.74 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.412 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.13 -32.6 97.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.62 2.213 . . . . 0.0 112.202 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.31 132.99 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' CD1' ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' CD1' ' CE2' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.53 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.432 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.436 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.407 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.5 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.588 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 29' ' ' LEU . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.01 129.31 30.21 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.565 2.177 . . . . 0.0 112.283 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mt -119.11 -69.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.67 -102.73 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -75.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 61.3 154.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.96 76.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 -45.37 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.56 123.51 64.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 17' ' ' TYR . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' PHE . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 96' ' ' PRO . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' A' ' 99' ' ' TYR . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 109' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.35 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.31 165.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.34 -54.68 0.74 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m 66.54 14.11 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 111.417 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 49.13 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.841 0.353 . . . . 0.0 111.243 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 69.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.98 -43.7 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.641 2.227 . . . . 0.0 112.618 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.11 158.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.288 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 17' ' ' TYR . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 17' ' ' TYR . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.454 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 32' ' ' PHE . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' CG1' ' CE2' ' A' ' 111' ' ' PHE . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.411 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 -27.14 26.59 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 mt 61.34 156.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.35 -116.07 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.17 105.11 15.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.63 -72.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.823 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.44 58.89 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 -45.43 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.0 112.17 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -116.91 130.49 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' TYR . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG21 HD12 ' A' ' 65' ' ' ILE . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.604 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 -45.94 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.628 2.219 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.48 102.99 6.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.58 163.48 5.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 172.89 3.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.5 -36.53 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.51 65.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.0 -41.66 2.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.601 2.2 . . . . 0.0 112.367 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.77 139.03 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 ' CE2' ' A' ' 32' ' ' PHE . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 96' ' ' PRO . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.603 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.524 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.4 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -36.75 68.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mt 60.35 174.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.28 46.69 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -124.0 95.27 4.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.08 168.65 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.58 61.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -41.53 3.28 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.566 2.177 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -107.67 144.49 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 32' ' ' PHE . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' N ' ' CD ' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD12 HG22 ' A' ' 65' ' ' ILE . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.405 ' HE3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.404 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 99' ' ' TYR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' OD1' ' HG ' ' A' ' 87' ' ' LEU . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 115' ' ' ASN . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.26 160.47 3.35 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.32 77.26 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.16 46.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 -50.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -108.5 42.14 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.46 52.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.54 -27.55 22.61 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.554 2.169 . . . . 0.0 112.356 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.1 145.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 32' ' ' PHE . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 41' ' ' LYS . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 67' ' ' LYS . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 65' ' ' ILE . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 47' ' ' TYR . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.3 p30 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.613 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.43 -61.89 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.3 110.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.78 -55.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.9 p -96.94 -177.14 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -146.02 102.7 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.89 57.25 0.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 -27.58 28.59 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.57 153.14 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' TYR . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 13' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' HG ' ' CD2' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.476 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.46 ' CE2' ' CG ' ' A' ' 31' ' ' GLU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 55' ' ' ALA . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' SER . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' N ' ' HB3' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' CD2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 99' ' ' TYR . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 54' ' ' TYR . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 10' ' ' THR . 7.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 9' ' ' VAL . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ALA . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' HA ' HG13 ' A' ' 12' ' ' VAL . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 16' ' ' ASN . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 28' ' ' VAL . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.508 HD13 ' OH ' ' A' ' 17' ' ' TYR . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HG3' ' CD1' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' OH ' HD22 ' A' ' 29' ' ' LEU . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 63' ' ' VAL . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 29' ' ' LEU . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.746 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 84' ' ' THR . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 84' ' ' THR . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 29' ' ' LEU . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 87' ' ' LEU . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.761 HG12 HD11 ' A' ' 109' ' ' ILE . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 99' ' ' TYR . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 105' ' ' VAL . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' CB ' HG11 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.855 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.531 HG11 ' HG2' ' A' ' 67' ' ' LYS . 21.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.701 HG21 ' CG1' ' A' ' 64' ' ' VAL . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.633 HG23 ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' OH ' HD13 ' A' ' 30' ' ' ILE . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 17' ' ' TYR . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.832 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' HD22 ' A' ' 87' ' ' LEU . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.708 HD22 ' OH ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' OH ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.625 ' OE1' HD12 ' A' ' 85' ' ' ILE . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.539 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 71' ' ' THR . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.652 ' HB3' HG22 ' A' ' 105' ' ' VAL . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' OH ' HD22 ' A' ' 29' ' ' LEU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 9' ' ' VAL . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.683 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.687 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 27' ' ' ASP . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HG2' HG11 ' A' ' 9' ' ' VAL . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.524 HG21 ' HG3' ' A' ' 35' ' ' PRO . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 79' ' ' ILE . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.852 HD12 HG21 ' A' ' 84' ' ' THR . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.815 HD13 ' O ' ' A' ' 84' ' ' THR . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.577 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' HG22 ' A' ' 97' ' ' VAL . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 22' ' ' LEU . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 115' ' ' ASN . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.718 HG12 HD11 ' A' ' 109' ' ' ILE . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 112' ' ' ILE . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.07 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.714 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.832 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.07 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 67' ' ' LYS . 21.5 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.842 0.354 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' OH ' HD13 ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 17' ' ' TYR . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 64' ' ' VAL . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD13 ' OH ' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.527 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB1' ' NE1' ' A' ' 36' ' ' TRP . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HG3' HG21 ' A' ' 71' ' ' THR . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.603 ' NE1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.59 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 50' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 55' ' ' ALA . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.683 HG21 ' HE3' ' A' ' 26' ' ' LYS . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 29' ' ' LEU . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.65 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 9' ' ' VAL . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 69' ' ' ASP . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.589 HG21 ' HG3' ' A' ' 35' ' ' PRO . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.737 HG12 HG21 ' A' ' 84' ' ' THR . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 84' ' ' THR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 87' ' ' LEU . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.807 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.807 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.795 ' CE2' HD23 ' A' ' 108' ' ' LEU . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 104' ' ' THR . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' ARG . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 46' ' ' LYS . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 112' ' ' ILE . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.409 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 109' ' ' ILE . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' CG ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.577 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 67' ' ' LYS . 21.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.824 0.345 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.869 HG23 ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 17' ' ' TYR . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 28' ' ' VAL . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.596 ' OD1' HG22 ' A' ' 25' ' ' THR . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.726 ' O ' HD22 ' A' ' 87' ' ' LEU . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 71' ' ' THR . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HB3' HG22 ' A' ' 105' ' ' VAL . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 43' ' ' LEU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 112' ' ' ILE . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 29' ' ' LEU . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.869 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 9' ' ' VAL . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 35' ' ' PRO . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.731 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.854 HD12 HG21 ' A' ' 84' ' ' THR . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 84' ' ' THR . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' N ' HD13 ' A' ' 87' ' ' LEU . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.719 HG11 ' CG ' ' A' ' 115' ' ' ASN . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 107' ' ' ASP . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 46' ' ' LYS . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 104' ' ' THR . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 85' ' ' ILE . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 112' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.975 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.719 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.975 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 10' ' ' THR . 21.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.877 0.37 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.75 HG23 ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 17' ' ' TYR . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 28' ' ' VAL . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 21' ' ' VAL . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 68' ' ' VAL . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.438 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.688 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.75 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.75 HG12 HG21 ' A' ' 84' ' ' THR . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.983 HD12 ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 115' ' ' ASN . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.416 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 115' ' ' ASN . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.983 ' CG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.488 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HE2' ' A' ' 54' ' ' TYR . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 29' ' ' LEU . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.999 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.733 ' CB ' HG21 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.877 HG11 ' HD2' ' A' ' 67' ' ' LYS . 19.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.888 0.375 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.864 HG23 ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' TYR . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' HG21 ' A' ' 21' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' O ' HG21 ' A' ' 28' ' ' VAL . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.876 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.685 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.685 HG22 ' OD1' ' A' ' 23' ' ' ASP . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HG2' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.876 HG11 ' HA ' ' A' ' 21' ' ' VAL . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.853 HD11 HG12 ' A' ' 68' ' ' VAL . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.477 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 71' ' ' THR . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.589 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 50' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 63' ' ' VAL . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE3' ' A' ' 26' ' ' LYS . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.578 HD12 ' HA2' ' A' ' 51' ' ' GLY . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.864 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.877 ' HD2' HG11 ' A' ' 9' ' ' VAL . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 30' ' ' ILE . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.533 HG21 ' HG3' ' A' ' 35' ' ' PRO . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 84' ' ' THR . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.602 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 108' ' ' LEU . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 28' ' ' VAL . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.711 HG11 ' CG ' ' A' ' 115' ' ' ASN . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.589 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 HD13 ' A' ' 85' ' ' ILE . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 112' ' ' ILE . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.035 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.711 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.035 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.79 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.893 HG23 ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 16' ' ' ASN . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' HD11 ' A' ' 87' ' ' LEU . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HD22 ' A' ' 87' ' ' LEU . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.874 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.823 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.703 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.662 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.874 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.893 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.79 ' CD ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.61 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.667 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.808 HG23 HG21 ' A' ' 84' ' ' THR . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 108' ' ' LEU . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 28' ' ' VAL . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.483 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.62 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 115' ' ' ASN . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.713 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 85' ' ' ILE . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.663 ' HA ' HD12 ' A' ' 112' ' ' ILE . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 109' ' ' ILE . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.724 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 48' ' ' GLU . 17.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.352 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.709 HG23 ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.655 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.52 HD11 ' CG1' ' A' ' 68' ' ' VAL . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 105' ' ' VAL . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' HD22 ' A' ' 29' ' ' LEU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 9' ' ' VAL . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.586 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.704 HG23 ' HB3' ' A' ' 29' ' ' LEU . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.709 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 30' ' ' ILE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.655 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 75' ' ' VAL . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.762 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.932 HD12 HG21 ' A' ' 84' ' ' THR . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 84' ' ' THR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 ' C ' ' A' ' 87' ' ' LEU . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 115' ' ' ASN . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 109' ' ' ILE . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.871 ' HA ' HD12 ' A' ' 109' ' ' ILE . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' CE2' ' A' ' 99' ' ' TYR . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 106' ' ' GLU . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 120' ' ' ALA . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.016 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.597 HD22 HG21 ' A' ' 97' ' ' VAL . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.902 0.382 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.526 ' C ' HD23 ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG12 ' CE2' ' A' ' 88' ' ' TYR . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 21' ' ' VAL . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 68' ' ' VAL . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.651 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HB2' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' HD22 ' A' ' 43' ' ' LEU . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.612 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.5 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.826 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 9' ' ' VAL . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 30' ' ' ILE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.597 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 79' ' ' ILE . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.882 HD12 HG21 ' A' ' 84' ' ' THR . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 84' ' ' THR . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.512 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 115' ' ' ASN . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' CE2' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' THR . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 103' ' ' ARG . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.534 HG23 ' HE2' ' A' ' 54' ' ' TYR . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.496 HD11 HD11 ' A' ' 29' ' ' LEU . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.946 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.946 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 67' ' ' LYS . 14.8 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.859 HG23 ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' TYR . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 68' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 20' ' ' ILE . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.848 ' O ' HD22 ' A' ' 87' ' ' LEU . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.902 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.846 HD11 HG11 ' A' ' 68' ' ' VAL . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.448 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 71' ' ' THR . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 29' ' ' LEU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.859 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' HG11 ' A' ' 9' ' ' VAL . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 30' ' ' ILE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 35' ' ' PRO . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.58 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 79' ' ' ILE . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 84' ' ' THR . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 108' ' ' LEU . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 29' ' ' LEU . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.902 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 117' ' ' LYS . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.692 ' OG ' HD21 ' A' ' 108' ' ' LEU . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 107' ' ' ASP . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 109' ' ' ILE . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.747 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 104' ' ' THR . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD21 ' OG ' ' A' ' 102' ' ' SER . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.845 ' HA ' HD12 ' A' ' 112' ' ' ILE . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.548 ' OD1' HD12 ' A' ' 87' ' ' LEU . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.38 -43.01 57.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 3' ' ' LEU . 8.9 tt -113.12 101.37 9.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.6 5.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.48 -163.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.42 131.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.57 49.1 80.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.713 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 96.5 Cg_endo -79.25 -41.42 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.528 2.152 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 10' ' ' THR . 7.7 t -99.98 160.44 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.148 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 9' ' ' VAL . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ALA . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' HA ' HG13 ' A' ' 12' ' ' VAL . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 16' ' ' ASN . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 28' ' ' VAL . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.508 HD13 ' OH ' ' A' ' 17' ' ' TYR . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HG3' ' CD1' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' OH ' HD22 ' A' ' 29' ' ' LEU . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 63' ' ' VAL . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 29' ' ' LEU . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.746 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 84' ' ' THR . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 84' ' ' THR . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 29' ' ' LEU . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 87' ' ' LEU . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.761 HG12 HD11 ' A' ' 109' ' ' ILE . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 99' ' ' TYR . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 105' ' ' VAL . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' CB ' HG11 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.855 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.19 115.54 4.2 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.573 2.182 . . . . 0.0 112.315 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mt -169.55 -63.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.97 -84.15 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.5 m -143.0 76.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 30.25 7.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.5 55.13 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.68 -47.1 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 0.0 112.299 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.531 HG11 ' HG2' ' A' ' 67' ' ' LYS . 21.8 t -75.35 151.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.701 HG21 ' CG1' ' A' ' 64' ' ' VAL . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.633 HG23 ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' OH ' HD13 ' A' ' 30' ' ' ILE . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 17' ' ' TYR . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.832 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' HD22 ' A' ' 87' ' ' LEU . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.708 HD22 ' OH ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' OH ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.625 ' OE1' HD12 ' A' ' 85' ' ' ILE . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.539 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 71' ' ' THR . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.652 ' HB3' HG22 ' A' ' 105' ' ' VAL . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' OH ' HD22 ' A' ' 29' ' ' LEU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 9' ' ' VAL . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.683 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.687 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 27' ' ' ASP . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HG2' HG11 ' A' ' 9' ' ' VAL . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.524 HG21 ' HG3' ' A' ' 35' ' ' PRO . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 79' ' ' ILE . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.852 HD12 HG21 ' A' ' 84' ' ' THR . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.815 HD13 ' O ' ' A' ' 84' ' ' THR . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.577 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' HG22 ' A' ' 97' ' ' VAL . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 22' ' ' LEU . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 115' ' ' ASN . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.718 HG12 HD11 ' A' ' 109' ' ' ILE . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 112' ' ' ILE . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.07 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.714 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.832 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.07 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.44 -171.89 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.47 2.113 . . . . 0.0 112.252 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.651 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -116.03 -14.99 11.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.334 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.638 ' N ' HD22 ' A' ' 3' ' ' LEU . . . 112.73 48.6 0.62 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.584 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.411 ' OG ' HD21 ' A' ' 3' ' ' LEU . 11.7 m -82.75 80.5 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.27 -77.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.02 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.88 61.74 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.412 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 19.1 Cg_endo -59.13 -32.6 97.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.62 2.213 . . . . 0.0 112.202 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 67' ' ' LYS . 21.5 t -144.31 132.99 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' OH ' HD13 ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 17' ' ' TYR . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 64' ' ' VAL . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD13 ' OH ' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.527 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB1' ' NE1' ' A' ' 36' ' ' TRP . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HG3' HG21 ' A' ' 71' ' ' THR . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.603 ' NE1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.59 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 50' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 55' ' ' ALA . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.683 HG21 ' HE3' ' A' ' 26' ' ' LYS . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 29' ' ' LEU . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.65 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 9' ' ' VAL . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 69' ' ' ASP . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.589 HG21 ' HG3' ' A' ' 35' ' ' PRO . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.737 HG12 HG21 ' A' ' 84' ' ' THR . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 84' ' ' THR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 87' ' ' LEU . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.463 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.807 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.807 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.795 ' CE2' HD23 ' A' ' 108' ' ' LEU . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 104' ' ' THR . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' ARG . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 46' ' ' LYS . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 112' ' ' ILE . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.409 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 109' ' ' ILE . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' CG ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.01 129.31 30.21 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.565 2.177 . . . . 0.0 112.283 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 6' ' ' GLU . 3.7 mt -119.11 -69.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.67 -102.73 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -75.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.1 mm-40 61.3 154.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.96 76.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 -45.37 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 67' ' ' LYS . 21.4 t -108.56 123.51 64.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.869 HG23 ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 17' ' ' TYR . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 28' ' ' VAL . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' OD1' HG22 ' A' ' 25' ' ' THR . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.726 ' O ' HD22 ' A' ' 87' ' ' LEU . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 71' ' ' THR . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HB3' HG22 ' A' ' 105' ' ' VAL . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 43' ' ' LEU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 112' ' ' ILE . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 29' ' ' LEU . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.869 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 9' ' ' VAL . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 35' ' ' PRO . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.731 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.854 HD12 HG21 ' A' ' 84' ' ' THR . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 84' ' ' THR . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' N ' HD13 ' A' ' 87' ' ' LEU . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.719 HG11 ' CG ' ' A' ' 115' ' ' ASN . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 107' ' ' ASP . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 46' ' ' LYS . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 104' ' ' THR . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 85' ' ' ILE . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 112' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.975 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.719 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.975 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.35 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.31 165.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.34 -54.68 0.74 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m 66.54 14.11 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 111.417 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 49.13 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.841 0.353 . . . . 0.0 111.243 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 69.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 98.4 Cg_endo -79.98 -43.7 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.641 2.227 . . . . 0.0 112.618 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 10' ' ' THR . 21.3 t -99.11 158.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.288 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.75 HG23 ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 17' ' ' TYR . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 28' ' ' VAL . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 21' ' ' VAL . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 68' ' ' VAL . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.663 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.438 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.688 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.75 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.75 HG12 HG21 ' A' ' 84' ' ' THR . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.983 HD12 ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 115' ' ' ASN . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.416 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 115' ' ' ASN . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.983 ' CG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.488 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HE2' ' A' ' 54' ' ' TYR . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 29' ' ' LEU . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.999 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.733 ' CB ' HG21 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 -27.14 26.59 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 mt 61.34 156.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.35 -116.07 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.17 105.11 15.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.63 -72.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.823 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.44 58.89 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 -45.43 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.0 112.17 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.877 HG11 ' HD2' ' A' ' 67' ' ' LYS . 19.1 t -116.91 130.49 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.864 HG23 ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 17' ' ' TYR . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' HG21 ' A' ' 21' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' O ' HG21 ' A' ' 28' ' ' VAL . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.876 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.685 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.685 HG22 ' OD1' ' A' ' 23' ' ' ASP . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HG2' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.876 HG11 ' HA ' ' A' ' 21' ' ' VAL . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.853 HD11 HG12 ' A' ' 68' ' ' VAL . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.477 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 71' ' ' THR . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.589 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 50' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 63' ' ' VAL . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE3' ' A' ' 26' ' ' LYS . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.578 HD12 ' HA2' ' A' ' 51' ' ' GLY . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.864 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.877 ' HD2' HG11 ' A' ' 9' ' ' VAL . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 30' ' ' ILE . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.533 HG21 ' HG3' ' A' ' 35' ' ' PRO . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 75' ' ' VAL . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 84' ' ' THR . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.602 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 108' ' ' LEU . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 28' ' ' VAL . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.711 HG11 ' CG ' ' A' ' 115' ' ' ASN . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.589 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 HD13 ' A' ' 85' ' ' ILE . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 112' ' ' ILE . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.035 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.711 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.035 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 3' ' ' LEU . 54.7 Cg_endo -69.69 -45.94 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.628 2.219 . . . . 0.0 112.284 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER -131.48 102.99 6.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.58 163.48 5.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 172.89 3.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.5 -36.53 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.51 65.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.0 -41.66 2.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.601 2.2 . . . . 0.0 112.367 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.79 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.6 t -115.77 139.03 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.893 HG23 ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 16' ' ' ASN . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' HD11 ' A' ' 87' ' ' LEU . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HD22 ' A' ' 87' ' ' LEU . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.874 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.823 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.703 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.662 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.874 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.893 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.79 ' CD ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.61 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.667 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.808 HG23 HG21 ' A' ' 84' ' ' THR . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 108' ' ' LEU . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 28' ' ' VAL . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.483 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.62 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 115' ' ' ASN . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.713 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 85' ' ' ILE . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.663 ' HA ' HD12 ' A' ' 112' ' ' ILE . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 109' ' ' ILE . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.724 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -36.75 68.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mt 60.35 174.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.28 46.69 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -124.0 95.27 4.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.08 168.65 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.58 61.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -41.53 3.28 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.566 2.177 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 48' ' ' GLU . 17.4 t -107.67 144.49 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.709 HG23 ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.655 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.52 HD11 ' CG1' ' A' ' 68' ' ' VAL . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 105' ' ' VAL . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' HD22 ' A' ' 29' ' ' LEU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 9' ' ' VAL . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.586 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.704 HG23 ' HB3' ' A' ' 29' ' ' LEU . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.709 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 30' ' ' ILE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.655 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 75' ' ' VAL . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.762 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.932 HD12 HG21 ' A' ' 84' ' ' THR . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 84' ' ' THR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 ' C ' ' A' ' 87' ' ' LEU . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 115' ' ' ASN . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 109' ' ' ILE . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.871 ' HA ' HD12 ' A' ' 109' ' ' ILE . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' CE2' ' A' ' 99' ' ' TYR . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 106' ' ' GLU . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 120' ' ' ALA . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.016 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.597 HD22 HG21 ' A' ' 97' ' ' VAL . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.26 160.47 3.35 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.32 77.26 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.16 46.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 -50.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -108.5 42.14 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.46 52.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.54 -27.55 22.61 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.554 2.169 . . . . 0.0 112.356 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.2 t -97.1 145.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.526 ' C ' HD23 ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG12 ' CE2' ' A' ' 88' ' ' TYR . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 21' ' ' VAL . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 68' ' ' VAL . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.651 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HB2' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' HD22 ' A' ' 43' ' ' LEU . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.612 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.5 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.826 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 9' ' ' VAL . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 30' ' ' ILE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.597 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 79' ' ' ILE . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.882 HD12 HG21 ' A' ' 84' ' ' THR . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 84' ' ' THR . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.512 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 115' ' ' ASN . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' CE2' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' THR . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 103' ' ' ARG . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.534 HG23 ' HE2' ' A' ' 54' ' ' TYR . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.496 HD11 HD11 ' A' ' 29' ' ' LEU . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.946 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.946 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.43 -61.89 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.3 110.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.78 -55.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.9 p -96.94 -177.14 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -146.02 102.7 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.89 57.25 0.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 -27.58 28.59 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 67' ' ' LYS . 14.8 t -88.57 153.14 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.859 HG23 ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' TYR . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 68' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 20' ' ' ILE . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.848 ' O ' HD22 ' A' ' 87' ' ' LEU . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.902 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.846 HD11 HG11 ' A' ' 68' ' ' VAL . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.448 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 71' ' ' THR . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 29' ' ' LEU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.859 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' HG11 ' A' ' 9' ' ' VAL . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 30' ' ' ILE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 35' ' ' PRO . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.58 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 75' ' ' VAL . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 79' ' ' ILE . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 84' ' ' THR . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 108' ' ' LEU . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 29' ' ' LEU . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.902 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 117' ' ' LYS . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.692 ' OG ' HD21 ' A' ' 108' ' ' LEU . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 107' ' ' ASP . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 109' ' ' ILE . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.747 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 104' ' ' THR . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD21 ' OG ' ' A' ' 102' ' ' SER . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.845 ' HA ' HD12 ' A' ' 112' ' ' ILE . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.548 ' OD1' HD12 ' A' ' 87' ' ' LEU . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 10' ' ' THR . 7.7 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 9' ' ' VAL . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ALA . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' HA ' HG13 ' A' ' 12' ' ' VAL . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 16' ' ' ASN . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 28' ' ' VAL . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.508 HD13 ' OH ' ' A' ' 17' ' ' TYR . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HG3' ' CD1' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' OH ' HD22 ' A' ' 29' ' ' LEU . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 63' ' ' VAL . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 29' ' ' LEU . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.746 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 84' ' ' THR . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 84' ' ' THR . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 29' ' ' LEU . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 87' ' ' LEU . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.761 HG12 HD11 ' A' ' 109' ' ' ILE . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 99' ' ' TYR . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 105' ' ' VAL . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' CB ' HG11 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.855 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.531 HG11 ' HG2' ' A' ' 67' ' ' LYS . 21.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.701 HG21 ' CG1' ' A' ' 64' ' ' VAL . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.633 HG23 ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' OH ' HD13 ' A' ' 30' ' ' ILE . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 17' ' ' TYR . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.832 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' HD22 ' A' ' 87' ' ' LEU . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.708 HD22 ' OH ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' OH ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.625 ' OE1' HD12 ' A' ' 85' ' ' ILE . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.539 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 71' ' ' THR . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.652 ' HB3' HG22 ' A' ' 105' ' ' VAL . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' OH ' HD22 ' A' ' 29' ' ' LEU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 9' ' ' VAL . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.683 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.687 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 27' ' ' ASP . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HG2' HG11 ' A' ' 9' ' ' VAL . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.524 HG21 ' HG3' ' A' ' 35' ' ' PRO . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 75' ' ' VAL . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 79' ' ' ILE . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.852 HD12 HG21 ' A' ' 84' ' ' THR . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.815 HD13 ' O ' ' A' ' 84' ' ' THR . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.577 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' HG22 ' A' ' 97' ' ' VAL . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 22' ' ' LEU . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 115' ' ' ASN . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.718 HG12 HD11 ' A' ' 109' ' ' ILE . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 112' ' ' ILE . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.07 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.714 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.832 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.07 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 67' ' ' LYS . 21.5 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.842 0.354 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' OH ' HD13 ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 17' ' ' TYR . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 64' ' ' VAL . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD13 ' OH ' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.527 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB1' ' NE1' ' A' ' 36' ' ' TRP . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HG3' HG21 ' A' ' 71' ' ' THR . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.603 ' NE1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.59 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 50' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 55' ' ' ALA . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.683 HG21 ' HE3' ' A' ' 26' ' ' LYS . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 29' ' ' LEU . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.65 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 9' ' ' VAL . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 69' ' ' ASP . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.589 HG21 ' HG3' ' A' ' 35' ' ' PRO . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.737 HG12 HG21 ' A' ' 84' ' ' THR . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 84' ' ' THR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.591 ' C ' HD13 ' A' ' 87' ' ' LEU . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.807 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.807 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.795 ' CE2' HD23 ' A' ' 108' ' ' LEU . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 104' ' ' THR . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' ARG . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 46' ' ' LYS . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 112' ' ' ILE . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 109' ' ' ILE . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' CG ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.577 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 67' ' ' LYS . 21.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.824 0.345 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.869 HG23 ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 HD21 ' A' ' 16' ' ' ASN . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.625 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 28' ' ' VAL . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.596 ' OD1' HG22 ' A' ' 25' ' ' THR . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.726 ' O ' HD22 ' A' ' 87' ' ' LEU . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 71' ' ' THR . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HB3' HG22 ' A' ' 105' ' ' VAL . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 43' ' ' LEU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 112' ' ' ILE . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 29' ' ' LEU . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.869 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 9' ' ' VAL . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 35' ' ' PRO . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.731 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.854 HD12 HG21 ' A' ' 84' ' ' THR . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 84' ' ' THR . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' N ' HD13 ' A' ' 87' ' ' LEU . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.719 HG11 ' CG ' ' A' ' 115' ' ' ASN . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 107' ' ' ASP . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 46' ' ' LYS . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 104' ' ' THR . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 85' ' ' ILE . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 112' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.975 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.719 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.975 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 10' ' ' THR . 21.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.877 0.37 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.75 HG23 ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 16' ' ' ASN . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.568 HD21 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 28' ' ' VAL . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 21' ' ' VAL . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 68' ' ' VAL . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.438 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.688 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.75 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.75 HG12 HG21 ' A' ' 84' ' ' THR . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.983 HD12 ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 115' ' ' ASN . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.416 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 115' ' ' ASN . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.983 ' CG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.488 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HE2' ' A' ' 54' ' ' TYR . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 29' ' ' LEU . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.999 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.733 ' CB ' HG21 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.877 HG11 ' HD2' ' A' ' 67' ' ' LYS . 19.1 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.888 0.375 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.864 HG23 ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 16' ' ' ASN . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.604 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' HG21 ' A' ' 21' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' O ' HG21 ' A' ' 28' ' ' VAL . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.876 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.685 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.685 HG22 ' OD1' ' A' ' 23' ' ' ASP . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HG2' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.876 HG11 ' HA ' ' A' ' 21' ' ' VAL . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.853 HD11 HG12 ' A' ' 68' ' ' VAL . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.477 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 71' ' ' THR . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.589 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 50' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 63' ' ' VAL . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE3' ' A' ' 26' ' ' LYS . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.578 HD12 ' HA2' ' A' ' 51' ' ' GLY . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.864 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.877 ' HD2' HG11 ' A' ' 9' ' ' VAL . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 30' ' ' ILE . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.533 HG21 ' HG3' ' A' ' 35' ' ' PRO . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 84' ' ' THR . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.602 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 108' ' ' LEU . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 28' ' ' VAL . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.711 HG11 ' CG ' ' A' ' 115' ' ' ASN . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.589 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 HD13 ' A' ' 85' ' ' ILE . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 112' ' ' ILE . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.035 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.711 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.035 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.79 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.893 HG23 ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 16' ' ' ASN . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' HD11 ' A' ' 87' ' ' LEU . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HD22 ' A' ' 87' ' ' LEU . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.874 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.823 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.662 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.874 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.893 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.79 ' CD ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.61 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.667 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.808 HG23 HG21 ' A' ' 84' ' ' THR . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 108' ' ' LEU . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 28' ' ' VAL . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.483 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.62 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 115' ' ' ASN . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.713 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 85' ' ' ILE . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.663 ' HA ' HD12 ' A' ' 112' ' ' ILE . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 109' ' ' ILE . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.724 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 48' ' ' GLU . 17.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.352 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.709 HG23 ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.655 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.52 HD11 ' CG1' ' A' ' 68' ' ' VAL . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 105' ' ' VAL . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' HD22 ' A' ' 29' ' ' LEU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 9' ' ' VAL . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.586 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.704 HG23 ' HB3' ' A' ' 29' ' ' LEU . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.709 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 30' ' ' ILE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.655 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 75' ' ' VAL . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.762 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.932 HD12 HG21 ' A' ' 84' ' ' THR . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 84' ' ' THR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 ' C ' HD13 ' A' ' 87' ' ' LEU . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 115' ' ' ASN . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 109' ' ' ILE . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.871 ' HA ' HD12 ' A' ' 109' ' ' ILE . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' CE2' ' A' ' 99' ' ' TYR . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 106' ' ' GLU . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 120' ' ' ALA . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.016 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.597 HD22 HG21 ' A' ' 97' ' ' VAL . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.902 0.382 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG22 HD21 ' A' ' 16' ' ' ASN . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.547 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.526 ' C ' HD23 ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG12 ' CE2' ' A' ' 88' ' ' TYR . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 21' ' ' VAL . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 68' ' ' VAL . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.651 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HB2' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' HD22 ' A' ' 43' ' ' LEU . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.612 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.5 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.826 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 9' ' ' VAL . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 30' ' ' ILE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.3 p30 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.597 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 79' ' ' ILE . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.882 HD12 HG21 ' A' ' 84' ' ' THR . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 84' ' ' THR . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.512 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 115' ' ' ASN . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' CE2' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' THR . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 103' ' ' ARG . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.534 HG23 ' HE2' ' A' ' 54' ' ' TYR . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.496 HD11 HD11 ' A' ' 29' ' ' LEU . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.946 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.946 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 67' ' ' LYS . 14.8 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.798 0.332 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.859 HG23 ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 HD21 ' A' ' 16' ' ' ASN . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 68' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 20' ' ' ILE . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.848 ' O ' HD22 ' A' ' 87' ' ' LEU . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.902 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.846 HD11 HG11 ' A' ' 68' ' ' VAL . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.448 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 71' ' ' THR . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 29' ' ' LEU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.859 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' HG11 ' A' ' 9' ' ' VAL . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 30' ' ' ILE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 35' ' ' PRO . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.58 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 79' ' ' ILE . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 84' ' ' THR . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 108' ' ' LEU . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 29' ' ' LEU . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.902 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 117' ' ' LYS . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.692 ' OG ' HD21 ' A' ' 108' ' ' LEU . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 107' ' ' ASP . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 109' ' ' ILE . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.747 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 104' ' ' THR . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD21 ' OG ' ' A' ' 102' ' ' SER . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.845 ' HA ' HD12 ' A' ' 112' ' ' ILE . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.548 ' OD1' HD12 ' A' ' 87' ' ' LEU . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.38 -43.01 57.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 3' ' ' LEU . 8.9 tt -113.12 101.37 9.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.6 5.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.48 -163.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.42 131.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 58.57 49.1 80.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.713 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 96.5 Cg_endo -79.25 -41.42 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.528 2.152 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 10' ' ' THR . 7.7 t -99.98 160.44 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.148 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 9' ' ' VAL . 85.1 m -72.71 143.22 48.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.46 131.42 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' CB ' ' A' ' 66' ' ' ALA . 45.0 t -128.71 108.61 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ALA . 11.9 p -113.46 160.91 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.764 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -46.48 -27.76 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -67.3 -28.07 67.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.389 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -139.08 23.28 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.649 0.261 . . . . 0.0 111.603 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' HA ' HG13 ' A' ' 12' ' ' VAL . 6.5 t80 -68.58 -43.84 75.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -68.64 -54.38 16.72 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.468 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -35.04 40.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 111.598 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 16' ' ' ASN . 21.6 mm -74.02 -78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.497 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 28' ' ' VAL . 43.9 t -43.85 -31.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.95 0.405 . . . . 0.0 111.385 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 25.6 mt -67.22 -41.67 85.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.073 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.52 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.974 0.416 . . . . 0.0 111.328 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.41 -14.28 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -70.43 -11.64 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.4 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -138.85 166.88 23.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 110.962 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.36 129.2 34.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.571 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.4 t -115.14 139.89 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.414 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -135.78 101.54 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.45 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.508 HD13 ' OH ' ' A' ' 17' ' ' TYR . 3.6 tt -104.21 130.94 54.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 111.41 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HG3' ' CD1' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -125.29 120.8 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.317 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.5 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -158.79 166.82 31.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.764 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.44 139.92 22.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.55 -7.39 21.18 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.508 2.139 . . . . 0.0 112.76 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -107.23 -25.13 11.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.742 0.306 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 t -66.3 136.53 55.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.002 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.9 -46.1 6.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -53.77 -29.61 40.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.872 0.368 . . . . 0.0 110.788 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.5 m -71.83 -32.02 67.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.59 -43.64 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.728 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.43 -12.61 60.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.133 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -61.09 -56.1 37.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.794 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 37.0 Cg_endo -66.31 -32.51 41.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.432 2.088 . . . . 0.0 112.921 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -67.96 -57.24 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' OH ' HD22 ' A' ' 29' ' ' LEU . 58.7 t80 -63.74 -29.05 70.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -36.79 70.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 1.5 tm-20 -65.7 -63.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -55.84 -30.65 61.79 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.967 0.413 . . . . 0.0 111.037 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.1 -65.68 3.39 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.122 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.71 -23.55 66.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.337 . . . . 0.0 111.052 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.35 -68.5 0.17 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 17.2 m-30 -84.22 -29.96 26.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.521 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.9 -27.53 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.545 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.35 -26.92 2.49 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.69 -58.05 3.37 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.95 -59.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CB ' HG12 ' A' ' 63' ' ' VAL . 6.1 m-85 -102.18 39.27 1.51 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.7 pttp -42.68 -42.48 3.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.952 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -118.41 36.44 4.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.001 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 27.8 mtt180 -143.91 -31.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.1 p -116.11 154.97 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 111.866 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.83 105.47 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.678 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 29' ' ' LEU . 41.0 mt -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.255 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.746 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -120.66 161.12 21.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 126.02 42.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.9 p -112.79 160.68 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.63 149.23 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.8 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.03 36.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.592 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -65.1 -57.07 9.56 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.6 110.67 1.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 111.721 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 176.51 -174.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 m-20 -54.16 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.5 p 42.13 59.65 9.8 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -26.5 82.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.266 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -74.07 143.96 45.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -84.05 155.37 22.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 84' ' ' THR . 6.0 mm -140.83 144.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.723 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -75.97 -41.48 51.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -135.53 -89.38 0.29 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -167.83 -60.35 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.006 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.616 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.4 Cg_endo -41.3 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 121.536 1.491 . . . . 0.0 110.407 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.931 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.34 148.36 40.67 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.753 -2.476 . . . . 0.0 111.979 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 84' ' ' THR . 5.7 mm -140.58 107.81 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.609 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 29' ' ' LEU . 5.2 mtmp? -112.61 146.43 38.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.227 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.9 tm? -129.57 121.93 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.41 108.23 46.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.562 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 38.3 Cg_endo -66.8 126.17 14.9 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.417 2.078 . . . . 0.0 112.433 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -59.86 115.92 3.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.0 -24.96 25.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.414 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -110.53 81.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -78.26 60.03 2.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.3 37.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 68.3 mm-40 -152.4 51.23 0.72 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 73.3 Cg_endo -75.95 125.44 8.69 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.481 2.121 . . . . 0.0 112.201 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 87' ' ' LEU . 35.2 m -78.94 152.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 114.95 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.968 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -75.78 138.21 41.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.817 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -95.79 22.24 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.47 112.37 1.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.8 p -67.58 125.85 27.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -105.08 -40.69 5.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.5 t -149.61 171.31 16.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.761 HG12 HD11 ' A' ' 109' ' ' ILE . 21.0 t -80.36 -36.75 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 pt-20 -58.25 -30.01 66.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.014 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.65 -40.27 34.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 99' ' ' TYR . 28.5 mt -63.71 -36.94 85.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.953 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 105' ' ' VAL . 5.3 mt -72.3 -50.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -61.05 -21.9 64.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.198 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -76.89 -45.49 27.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -57.74 -37.93 62.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -83.81 -23.44 31.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.342 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.66 -52.16 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.119 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' CB ' HG11 ' A' ' 97' ' ' VAL . 21.3 p30 -83.77 -29.84 27.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.101 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.01 134.58 37.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.593 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -35.03 71.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -82.02 -12.43 58.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 62.91 50.3 3.28 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.6 85.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.855 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.06 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.19 115.54 4.2 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.573 2.182 . . . . 0.0 112.315 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mt -169.55 -63.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.97 -84.15 0.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.5 m -143.0 76.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 30.25 7.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.5 55.13 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.68 -47.1 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 0.0 112.299 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.531 HG11 ' HG2' ' A' ' 67' ' ' LYS . 21.8 t -75.35 151.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.701 HG21 ' CG1' ' A' ' 64' ' ' VAL . 67.4 m -82.01 143.37 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.9 117.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.633 HG23 ' CB ' ' A' ' 66' ' ' ALA . 12.8 t -121.34 102.57 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.0 p -113.69 161.21 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.646 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.47 -28.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.6 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -35.2 76.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -139.6 26.0 2.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' OH ' HD13 ' A' ' 30' ' ' ILE . 7.9 t80 -67.19 -44.93 78.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.793 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m120 -65.96 -54.8 21.6 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.458 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.96 -35.53 34.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 111.618 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.6 mm -74.29 -77.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 17' ' ' TYR . 40.9 t -44.08 -30.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.954 0.407 . . . . 0.0 111.33 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 23.3 mt -67.12 -42.84 83.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.115 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.59 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.4 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -84.41 -10.73 57.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.586 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.2 p -70.18 -11.05 60.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.456 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 17.1 mttp -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.832 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 2.3 p30 -81.45 127.79 33.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.586 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' HD22 ' A' ' 87' ' ' LEU . 81.7 t -113.81 147.98 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.708 HD22 ' OH ' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -136.61 102.9 5.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' OH ' ' A' ' 17' ' ' TYR . 9.5 tt -106.88 135.99 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.219 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.625 ' OE1' HD12 ' A' ' 85' ' ' ILE . 29.7 tt0 -127.7 120.48 28.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.539 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 1.9 m-85 -95.96 145.86 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.805 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -161.76 167.37 25.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.927 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.72 142.28 25.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.785 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 71' ' ' THR . 58.3 Cg_endo -72.16 -5.06 16.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 112.722 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.426 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -108.46 -26.37 10.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 110.884 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.3 t -74.45 143.34 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.99 -22.17 59.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.678 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -55.06 -29.95 58.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.11 -34.89 78.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -62.17 -39.3 92.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.25 64.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -101.74 0.68 36.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.304 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -61.4 3.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.478 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 Cg_endo -69.75 -29.53 23.76 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.523 2.148 . . . . 0.0 112.566 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.652 ' HB3' HG22 ' A' ' 105' ' ' VAL . 16.0 mmtt -70.94 -57.01 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' OH ' HD22 ' A' ' 29' ' ' LEU . 6.5 t80 -65.09 -30.3 71.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 9' ' ' VAL . 6.0 tt0 -68.95 -39.49 79.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -66.06 -63.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -55.49 -31.58 62.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.104 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.683 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.79 -65.65 3.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.186 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.84 -23.48 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.116 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -50.55 -68.49 0.17 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.369 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CE2' HD21 ' A' ' 50' ' ' LEU . 16.0 m-30 -84.19 -29.32 26.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.427 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.687 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.87 -27.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.532 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -129.5 -26.86 2.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.8 m -79.44 -58.29 3.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -97.04 -59.95 1.69 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 120' ' ' ALA . 65.1 m-85 -103.47 39.42 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.312 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -42.24 -37.99 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.46 28.94 8.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.107 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -147.61 6.21 0.82 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 27' ' ' ASP . 5.6 p -145.39 147.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.042 0.449 . . . . 0.0 111.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.49 105.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.4 mt -106.45 108.06 24.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -119.59 163.05 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 111.51 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HG2' HG11 ' A' ' 9' ' ' VAL . 15.4 pttt -127.55 125.02 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.7 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.1 p -116.06 160.98 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -110.91 149.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.94 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.743 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.524 HG21 ' HG3' ' A' ' 35' ' ' PRO . 33.7 p -65.12 -60.1 3.39 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.43 110.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.984 0.421 . . . . 0.0 111.612 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 175.52 -175.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.531 179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -50.1 -77.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 75' ' ' VAL . 8.9 p 41.85 53.23 7.49 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.764 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.8 Cg_endo -60.17 -26.07 81.6 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.6 2.2 . . . . 0.0 112.286 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.66 155.4 40.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 79' ' ' ILE . 6.9 pt-20 -88.05 151.83 22.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.831 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.852 HD12 HG21 ' A' ' 84' ' ' THR . 25.8 mm -142.51 136.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.576 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -76.06 -42.73 46.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -131.8 -86.89 0.36 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.922 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 m-85 -169.84 -60.16 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.015 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.2 Cg_endo -43.18 73.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 121.334 1.356 . . . . 0.0 110.022 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.922 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.3 p -116.65 147.28 42.07 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 111.684 -2.507 . . . . 0.0 112.107 -175.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.815 HD13 ' O ' ' A' ' 84' ' ' THR . 4.7 mm -139.73 107.81 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.401 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.577 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.4 mttp -109.88 148.51 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.419 . . . . 0.0 111.284 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' HG22 ' A' ' 97' ' ' VAL . 3.0 tm? -129.5 119.27 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.514 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -94.19 105.5 17.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 37.5 Cg_endo -65.99 122.33 9.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.412 2.075 . . . . 0.0 112.297 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -62.55 128.18 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.85 -29.09 10.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.2 74.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.853 0.359 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE2' HD23 ' A' ' 22' ' ' LEU . 12.2 tttm -70.6 65.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.12 39.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 25.8 mm100 -155.15 50.73 0.53 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 78.7 Cg_endo -77.32 134.36 14.07 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.446 2.097 . . . . 0.0 112.151 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 115' ' ' ASN . 21.2 m -86.6 152.7 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 116.64 21.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -88.66 138.2 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -95.4 22.32 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.29 113.02 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.71 143.46 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.915 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -111.45 -30.74 7.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 t -141.31 165.39 27.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.718 HG12 HD11 ' A' ' 109' ' ' ILE . 21.3 t -80.36 -32.64 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.68 -29.58 68.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.59 -37.85 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.17 -38.68 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.751 ' HA ' HD12 ' A' ' 112' ' ' ILE . 6.2 mt -70.89 -49.8 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -59.99 -24.0 64.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -73.49 -47.48 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.0 mt -55.14 -42.96 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.07 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -80.4 -19.58 45.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.395 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -52.17 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.714 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -89.47 -37.23 14.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.722 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.99 114.51 6.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.507 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.1 -40.88 74.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.17 -12.89 61.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 61.83 57.04 2.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.832 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -67.39 73.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.07 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.044 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.44 -171.89 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.47 2.113 . . . . 0.0 112.252 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -116.03 -14.99 11.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.334 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.638 ' N ' HD22 ' A' ' 3' ' ' LEU . . . 112.73 48.6 0.62 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.584 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.411 ' OG ' HD21 ' A' ' 3' ' ' LEU . 11.7 m -82.75 80.5 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.27 -77.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.02 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.88 61.74 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.412 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 19.1 Cg_endo -59.13 -32.6 97.52 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.62 2.213 . . . . 0.0 112.202 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 67' ' ' LYS . 21.5 t -144.31 132.99 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 83.0 m -73.51 143.59 46.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.75 108.91 24.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG23 ' CB ' ' A' ' 66' ' ' ALA . 3.4 t -106.94 111.07 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 110.834 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -120.98 162.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.599 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -49.07 -26.23 2.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -65.35 -33.53 76.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.56 27.27 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.709 0.29 . . . . 0.0 111.523 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' OH ' HD13 ' A' ' 30' ' ' ILE . 9.0 t80 -67.85 -46.09 72.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 110.799 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.5 m-80 -64.47 -55.58 19.86 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.286 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.04 -35.96 27.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.897 0.38 . . . . 0.0 111.649 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 16' ' ' ASN . 24.9 mm -74.06 -79.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.685 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 17' ' ' TYR . 25.7 t -43.5 -30.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.996 0.427 . . . . 0.0 111.527 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.4 mt -67.09 -43.26 82.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.099 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.48 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.462 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -84.5 -10.75 57.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.449 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -9.96 57.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.587 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' HE3' HG21 ' A' ' 64' ' ' VAL . 7.1 pttt -143.61 169.73 17.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.048 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.35 129.09 34.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.6 t -115.17 139.71 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 111.353 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.863 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.17 97.85 3.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.633 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD13 ' OH ' ' A' ' 17' ' ' TYR . 14.1 tt -102.06 133.89 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.951 0.405 . . . . 0.0 111.58 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 1.8 tm-20 -125.92 121.19 32.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.366 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.527 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.2 m-85 -95.56 147.54 23.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.38 . . . . 0.0 110.911 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 6.5 p90 -164.31 164.51 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB1' ' NE1' ' A' ' 36' ' ' TRP . . . -108.49 148.08 36.96 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HG3' HG21 ' A' ' 71' ' ' THR . 74.2 Cg_endo -76.39 2.95 6.75 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.463 2.109 . . . . 0.0 112.747 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.603 ' NE1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -116.74 -21.28 9.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.236 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.3 t -70.88 134.04 46.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.842 0.354 . . . . 0.0 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -82.2 -31.17 32.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.98 -42.92 99.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 0.0 111.011 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 33' ' ' TYR . 23.5 p -66.29 -30.97 71.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -57.59 -38.21 74.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.913 0.387 . . . . 0.0 110.399 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.43 -29.49 63.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.679 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -82.04 0.94 38.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.334 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -67.54 -61.11 4.79 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.528 0.204 . . . . 0.0 111.307 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.59 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 22.2 Cg_endo -61.45 -34.54 86.0 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.494 2.129 . . . . 0.0 112.318 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.1 mttp -66.8 -52.86 38.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 13.1 t80 -61.54 -28.59 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.15 -31.11 60.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.713 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.05 -62.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.615 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.55 HD13 ' C ' ' A' ' 50' ' ' LEU . 2.1 tm? -60.35 -40.45 90.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -49.28 -66.54 2.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.636 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . . . -66.49 -23.76 66.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 0.0 110.959 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -47.18 -69.03 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.3 m-30 -84.88 -33.38 22.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.374 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -29.81 3.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.82 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.6 tptm -129.91 -27.78 2.27 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 2.6 t -79.77 -58.52 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.33 -60.03 1.66 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 3.7 m-30 -101.01 39.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.159 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 4.8 ptmt -42.32 -40.15 2.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.875 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -118.47 29.79 7.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.966 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . 1.4 mmp_? -135.85 -30.24 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 55' ' ' ALA . 7.9 p -115.13 154.89 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.409 . . . . 0.0 111.925 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.683 HG21 ' HE3' ' A' ' 26' ' ' LYS . 23.5 t -143.4 106.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.721 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.863 HG23 ' HB3' ' A' ' 29' ' ' LEU . 29.9 mt -110.27 120.24 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.568 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.65 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.96 168.02 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.268 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 9' ' ' VAL . 6.0 pttt -133.78 131.05 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.926 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 69' ' ' ASP . 14.9 p -120.2 161.03 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.58 149.43 29.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.16 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 1.86 30.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.759 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.589 HG21 ' HG3' ' A' ' 35' ' ' PRO . 73.3 p -65.21 -48.65 72.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.428 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -172.89 116.7 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.017 0.437 . . . . 0.0 111.256 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER 169.94 -174.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.454 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.33 -75.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.3 p 41.62 52.43 6.47 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.911 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.5 Cg_endo -66.14 -26.51 49.89 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.497 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.79 173.48 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.53 143.71 29.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.737 HG12 HG21 ' A' ' 84' ' ' THR . 3.2 mt -143.44 136.03 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -82.08 -28.86 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 109.282 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.98 -82.01 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -168.3 -60.26 0.01 OUTLIER Pre-proline 0 CA--C 1.472 -2.03 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 5.5 Cg_endo -45.09 73.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 121.072 1.182 . . . . 0.0 109.537 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.932 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -116.39 147.97 41.11 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.358 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 84' ' ' THR . 4.6 mm -141.48 114.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.249 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -119.46 148.2 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.254 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.591 ' C ' HD13 ' A' ' 87' ' ' LEU . 2.0 tm? -129.12 122.0 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.463 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -98.49 107.34 41.76 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.81 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.807 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 54.0 Cg_endo -69.44 124.7 11.48 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.415 2.077 . . . . 0.0 112.09 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -56.43 123.49 14.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.85 -24.24 32.56 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.807 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -103.87 72.57 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -69.89 71.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.757 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.21 39.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.7 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 2.0 mm-40 -141.92 52.18 2.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 33.9 Cg_exo -59.15 120.46 8.34 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.409 2.073 . . . . 0.0 112.364 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -77.89 144.1 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.497 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.89 111.1 16.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.586 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.795 ' CE2' HD23 ' A' ' 108' ' ' LEU . 2.4 m-85 -69.88 138.26 52.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 111.127 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.9 m -84.99 -33.02 22.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.43 86.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.428 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.9 p -59.48 102.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HG22 ' A' ' 104' ' ' THR . 21.6 ptt85 -89.23 -27.11 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.97 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' ARG . 9.7 t -147.11 175.92 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 46' ' ' LYS . 43.5 t -80.4 -50.94 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -44.62 -30.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.553 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.78 -40.63 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 99' ' ' TYR . 3.4 mt -59.54 -40.49 87.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 112' ' ' ILE . 11.3 mt -69.26 -47.22 74.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -57.38 -23.91 52.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -75.09 -53.8 8.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.602 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 109' ' ' ILE . 8.0 mt -46.66 -39.99 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.339 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 121' ' ' ALA . . . -84.0 -20.61 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.613 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.87 -45.55 35.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.576 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' CG ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -99.82 -30.38 12.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.071 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.81 121.85 28.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.474 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -57.51 -42.28 82.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.925 0.393 . . . . 0.0 110.728 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -16.44 61.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.029 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 57.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.618 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -59.48 83.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.01 129.31 30.21 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.565 2.177 . . . . 0.0 112.283 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 6' ' ' GLU . 3.7 mt -119.11 -69.13 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.67 -102.73 0.67 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -75.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' CG ' HD13 ' A' ' 3' ' ' LEU . 1.1 mm-40 61.3 154.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.96 76.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 -45.37 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.716 HG11 ' HD2' ' A' ' 67' ' ' LYS . 21.4 t -108.56 123.51 64.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.0 m -58.79 143.39 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -99.9 135.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.375 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.869 HG23 ' CB ' ' A' ' 66' ' ' ALA . 21.1 t -120.75 143.09 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 HD21 ' A' ' 16' ' ' ASN . 5.5 m -155.56 164.87 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' N ' ' A' ' 74' ' ' ASP . . . -53.19 -22.9 7.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.2 -31.9 64.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.651 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.625 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -136.15 23.16 3.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.8 t80 -69.38 -44.32 71.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.06 0.457 . . . . 0.0 110.582 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 7.0 m120 -69.05 -55.8 9.68 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.373 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -36.46 25.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 111.702 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.82 -79.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG11 ' A' ' 28' ' ' VAL . 38.4 t -43.73 -30.19 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.678 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.6 mt -67.11 -44.22 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' OD1' HG22 ' A' ' 25' ' ' THR . 2.5 t0 -45.56 93.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 111.253 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' LEU . 5.0 p-10 -84.28 -16.37 43.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.442 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.2 t -70.47 -12.49 61.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.8 165.81 24.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.333 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.33 131.15 35.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.268 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.726 ' O ' HD22 ' A' ' 87' ' ' LEU . 88.2 t -117.87 136.93 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 111.683 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.1 100.0 4.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.259 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.48 141.0 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.649 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -132.63 122.52 24.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.289 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HE2' ' HH ' ' A' ' 17' ' ' TYR . 3.0 m-85 -99.64 142.36 31.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 111.265 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.0 p90 -156.29 174.91 14.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -115.59 140.01 25.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG3' HG21 ' A' ' 71' ' ' THR . 55.7 Cg_endo -70.24 -10.86 29.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.503 2.135 . . . . 0.0 112.541 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -106.1 -28.96 10.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 10.7 t -67.47 143.33 56.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.93 -19.72 69.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.763 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -58.44 -31.47 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 111.099 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.27 -37.97 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.98 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -63.4 -47.95 79.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.24 1.09 57.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.372 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.24 -58.55 12.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.34 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.4 Cg_endo -71.42 -27.44 19.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.519 2.146 . . . . 0.0 112.6 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HB3' HG22 ' A' ' 105' ' ' VAL . 7.5 mmmt -71.29 -57.17 4.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 43' ' ' LEU . 14.5 t80 -66.53 -27.74 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.17 -34.58 66.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.799 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.68 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.825 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 112' ' ' ILE . 1.8 tm? -58.44 -41.62 85.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -49.18 -66.58 2.13 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.825 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.25 -23.62 66.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 111.031 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -48.69 -68.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.528 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 21.3 m-30 -84.74 -31.89 23.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.357 . . . . 0.0 111.514 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.674 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.77 -30.9 4.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.84 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.97 -27.48 2.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -79.81 -58.09 3.34 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -96.93 -59.89 1.7 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 88.5 m-85 -102.63 39.4 1.53 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.373 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.56 -38.86 2.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.749 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -118.31 36.5 4.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.831 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -145.64 -35.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 7.6 p -107.92 154.58 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.991 0.425 . . . . 0.0 111.894 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.51 105.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.396 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 29' ' ' LEU . 4.8 mt -115.37 115.43 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.432 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.869 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -128.22 166.7 18.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.716 ' HD2' HG11 ' A' ' 9' ' ' VAL . 2.3 ptmt -132.55 124.95 29.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.5 p -116.6 160.01 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -103.37 149.21 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.3 2.37 28.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.801 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.565 HG21 ' HG3' ' A' ' 35' ' ' PRO . 23.2 p -64.9 -57.85 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.93 108.33 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.981 0.42 . . . . 0.0 111.698 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER 175.94 -174.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.546 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -49.59 -78.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.89 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.2 p 42.15 53.1 7.74 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.736 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 17' ' ' TYR . 19.5 Cg_endo -58.42 -26.12 76.4 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.577 2.185 . . . . 0.0 112.268 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.39 153.65 35.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.731 ' O ' HD13 ' A' ' 79' ' ' ILE . 1.4 tt0 -90.46 155.35 18.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.854 HD12 HG21 ' A' ' 84' ' ' THR . 12.0 mm -143.67 145.49 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.594 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.94 -46.63 28.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.27 -89.05 0.56 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.7 m-85 -167.79 -60.44 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.982 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.622 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.6 Cg_endo -41.29 72.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 121.495 1.463 . . . . 0.0 110.44 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -115.15 148.44 39.02 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.688 -2.505 . . . . 0.0 112.066 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 84' ' ' THR . 7.6 mm -139.35 107.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.558 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -110.72 149.39 30.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD23 ' HG ' ' A' ' 29' ' ' LEU . 2.3 tm? -130.66 119.01 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.869 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' N ' HD13 ' A' ' 87' ' ' LEU . 1.1 m-85 -97.61 102.79 14.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.334 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.1 124.84 14.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.387 2.058 . . . . 0.0 112.364 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.91 125.83 24.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.74 19.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.91 81.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 0.0 111.012 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 59.62 3.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.912 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.07 36.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 90.8 mm-40 -154.17 52.23 0.75 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.759 0.314 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 72.3 Cg_endo -76.53 128.72 10.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.545 2.163 . . . . 0.0 112.305 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.719 HG11 ' CG ' ' A' ' 115' ' ' ASN . 33.3 m -78.67 152.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.042 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.93 108.47 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -78.85 138.13 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -95.96 22.29 7.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.49 96.3 2.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.8 p -71.31 166.77 20.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -138.05 16.5 2.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 107' ' ' ASP . 11.9 t -177.38 145.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 46' ' ' LYS . 42.4 t -65.27 -49.28 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.062 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -45.45 -29.22 1.05 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 104' ' ' THR . 5.0 m-20 -78.44 -41.4 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 85' ' ' ILE . 18.8 mt -62.86 -36.12 82.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 112' ' ' ILE . 8.8 mt -69.89 -56.05 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.35 -23.88 40.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.498 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -71.7 -46.96 57.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.542 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -53.04 -43.58 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.012 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.975 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.9 -19.39 52.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.31 -52.22 9.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.719 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -92.5 -33.43 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.089 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.0 116.12 8.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.523 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -41.59 75.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.832 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.0 -20.24 62.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.96 59.13 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.645 ' HB3' ' CG2' ' A' ' 112' ' ' ILE . . . -68.98 68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.975 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.35 -71.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.31 165.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.34 -54.68 0.74 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m 66.54 14.11 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 111.417 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 49.13 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.841 0.353 . . . . 0.0 111.243 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 69.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.469 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 98.4 Cg_endo -79.98 -43.7 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.641 2.227 . . . . 0.0 112.618 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 10' ' ' THR . 21.3 t -99.11 158.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.288 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.2 m -90.04 143.31 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.83 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.2 t -99.19 120.52 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.75 HG23 ' CB ' ' A' ' 66' ' ' ALA . 34.9 t -117.06 151.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 16' ' ' ASN . 1.3 m -155.63 165.78 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.647 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 73' ' ' ASN . . . -52.91 -23.01 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.163 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -74.56 -37.24 63.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.525 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.568 HD21 HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -125.47 22.09 7.74 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 13' ' ' VAL . 8.8 t80 -71.3 -43.1 67.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.9 m120 -70.83 -54.51 11.32 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.406 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -51.95 -36.14 48.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.942 0.401 . . . . 0.0 111.564 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.4 mm -73.96 -77.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.452 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG11 ' A' ' 28' ' ' VAL . 45.5 t -44.12 -30.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.485 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 20.3 mt -67.14 -43.84 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.51 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.6 m-20 -84.35 -10.9 57.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.531 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 t -70.28 -11.39 60.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.587 0.232 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.88 168.45 19.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 133.94 35.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 21' ' ' VAL . 87.3 t -118.7 140.09 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.369 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.7 97.78 3.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.66 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 68' ' ' VAL . 5.3 tt -105.9 134.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.044 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.5 tm-20 -125.19 122.37 36.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 1.8 m-85 -96.06 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 16.9 p90 -158.41 165.81 33.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -110.08 138.36 20.78 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.4 -10.37 28.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.509 2.139 . . . . 0.0 112.596 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -105.9 -23.28 12.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.943 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 5.8 t -78.16 115.41 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -22.17 31.38 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.787 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -28.63 55.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.12 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.1 p -68.05 -34.49 76.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -40.6 97.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.14 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.141 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -99.11 0.87 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.422 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.11 -60.79 3.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.514 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 56.0 Cg_endo -70.58 -33.07 14.11 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.532 2.155 . . . . 0.0 112.656 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -67.81 -57.19 6.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 24.2 t80 -65.95 -29.63 70.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -70.18 -37.41 75.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.005 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.4 tt0 -66.56 -63.03 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.025 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -56.55 -31.96 64.69 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.048 0.452 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -54.86 -66.31 2.91 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.05 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . . . -65.61 -23.59 66.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.739 0.304 . . . . 0.0 111.079 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.0 mt -49.14 -68.42 0.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.125 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.5 m-85 -84.63 -33.79 23.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.847 0.356 . . . . 0.0 111.397 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.93 -29.09 3.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.745 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 16.7 mmtm -129.45 -27.66 2.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.1 t -80.14 -58.29 3.22 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -97.17 -59.93 1.69 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.4 m-85 -98.69 38.98 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 110.972 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 ptpp? -42.69 -43.08 3.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.768 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -118.6 31.24 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.963 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.438 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 10.7 mmt85 -137.72 -25.08 1.01 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 59' ' ' PHE . 7.9 p -123.44 154.99 29.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.952 0.406 . . . . 0.0 111.828 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.93 105.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.82 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.688 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -108.45 108.13 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.75 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -117.92 160.8 20.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.429 . . . . 0.0 111.271 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -125.01 125.33 43.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.906 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 69' ' ' ASP . 11.7 p -121.5 159.15 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.175 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.83 149.35 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.945 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.62 2.3 22.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.812 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -64.74 -48.69 73.65 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -166.02 106.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 0.0 111.923 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER 174.11 -175.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.605 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.407 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -50.35 -77.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.093 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.3 p 41.85 52.0 6.31 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -68.06 -28.55 34.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.52 2.147 . . . . 0.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -55.9 163.63 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.14 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.11 140.51 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.75 HG12 HG21 ' A' ' 84' ' ' THR . 4.2 mt -143.23 125.1 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.386 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.61 -27.26 55.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.361 0.6 . . . . 0.0 109.547 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -148.47 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.919 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.1 m-85 -169.12 -60.03 0.0 OUTLIER Pre-proline 0 CA--C 1.473 -2.011 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.597 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 4.3 Cg_endo -43.84 73.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.235 1.29 . . . . 0.0 109.976 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.919 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -117.62 148.46 41.91 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.691 -2.504 . . . . 0.0 112.2 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.983 HD12 ' CG ' ' A' ' 99' ' ' TYR . 3.3 mt -138.07 107.69 4.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.299 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 2.1 mptp? -104.39 130.52 52.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.098 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 115' ' ' ASN . 1.9 tm? -116.66 114.47 24.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.69 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.416 ' N ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -95.42 103.37 12.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.69 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 42.9 Cg_endo -67.88 126.44 14.59 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.43 2.087 . . . . 0.0 112.335 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -59.43 124.01 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.73 -27.65 16.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.481 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -107.69 80.42 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.364 . . . . 0.0 111.032 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -78.05 62.05 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.55 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -147.45 55.57 2.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.79 0.328 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 115.75 3.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.597 2.198 . . . . 0.0 112.205 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.733 HG21 ' CB ' ' A' ' 115' ' ' ASN . 62.1 t -91.11 118.91 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 m -103.51 132.13 50.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.805 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.983 ' CG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -69.95 136.96 51.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.96 22.34 9.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.032 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.36 116.2 2.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.1 p -58.05 122.41 12.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 110.979 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -108.6 -35.89 6.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -177.48 162.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.48 -50.86 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -50.16 -27.99 6.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -39.33 43.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.488 HD23 ' CE1' ' A' ' 99' ' ' TYR . 19.1 mt -64.39 -34.74 78.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.611 HG23 ' HE2' ' A' ' 54' ' ' TYR . 25.6 mt -72.46 -51.82 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.073 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -22.69 64.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' ' CG1' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -72.01 -52.43 17.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 29' ' ' LEU . 12.7 mt -53.22 -44.97 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.485 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.999 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -75.19 -23.79 57.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.28 -52.16 11.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.014 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.733 ' CB ' HG21 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -87.8 -40.82 13.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.94 114.0 5.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.552 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -38.73 70.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -20.06 65.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.992 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 67.43 49.87 0.99 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.424 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -67.84 72.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.214 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 -27.14 26.59 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 mt 61.34 156.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.35 -116.07 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.17 105.11 15.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.63 -72.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.823 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.44 58.89 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 -45.43 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.0 112.17 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.877 HG11 ' HD2' ' A' ' 67' ' ' LYS . 19.1 t -116.91 130.49 71.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 96.3 m -61.22 143.38 55.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.59 130.4 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.864 HG23 ' CB ' ' A' ' 66' ' ' ALA . 27.3 t -117.1 142.98 28.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.593 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 16' ' ' ASN . 3.6 m -154.05 163.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -24.57 5.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.271 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -70.86 -37.86 73.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.604 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -127.82 29.26 5.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.23 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' HG21 ' A' ' 21' ' ' VAL . 11.4 t80 -76.36 -40.27 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.5 m120 -72.66 -53.32 12.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.11 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -54.97 -41.12 70.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.299 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' O ' HG21 ' A' ' 28' ' ' VAL . 29.7 mm -78.18 -75.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.876 ' HA ' HG11 ' A' ' 28' ' ' VAL . 57.2 t -45.6 -42.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.06 -23.59 41.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.685 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -46.37 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 111.279 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.4 p30 -73.94 -10.84 60.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.685 HG22 ' OD1' ' A' ' 23' ' ' ASP . 8.9 t -70.39 -11.36 60.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.364 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.646 ' HG2' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -151.46 170.18 20.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -81.32 125.74 30.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.876 HG11 ' HA ' ' A' ' 21' ' ' VAL . 68.0 t -112.53 144.83 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.383 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -133.54 99.11 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.531 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.853 HD11 HG12 ' A' ' 68' ' ' VAL . 5.0 tp -101.28 127.63 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.323 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -124.44 113.65 18.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.319 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.477 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 2.3 m-85 -93.64 147.23 23.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 111.036 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -162.54 173.15 14.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.865 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.02 142.02 27.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 71' ' ' THR . 60.3 Cg_endo -73.01 -5.28 16.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.501 2.134 . . . . 0.0 112.815 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.81 -27.39 10.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.908 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.2 t -72.02 143.4 49.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.72 -20.12 66.59 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.692 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -56.51 -32.29 64.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.075 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.4 p -71.38 -30.66 66.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -59.91 -42.88 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.55 -35.16 60.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.589 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -84.41 -4.96 59.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.205 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.02 -59.47 5.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.463 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 53.0 Cg_endo -69.87 -35.03 13.05 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.457 2.105 . . . . 0.0 112.651 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -67.62 -57.23 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.074 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.6 t80 -63.84 -30.44 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.81 -34.84 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.041 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.9 OUTLIER -67.75 -63.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.972 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.575 HD13 ' C ' ' A' ' 50' ' ' LEU . 3.0 tm? -57.68 -31.69 66.6 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.059 0.457 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -55.05 -66.15 3.04 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.055 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.56 -23.48 66.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 111.074 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LEU . 6.9 mt -49.93 -68.67 0.15 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.21 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.511 ' CE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-30 -84.46 -31.31 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.537 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.88 -26.91 1.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.565 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.2 mtpt -129.31 -27.19 2.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 17.2 m -79.87 -58.09 3.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -96.95 -59.85 1.71 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CB ' HG12 ' A' ' 63' ' ' VAL . 4.8 m-85 -101.81 39.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.221 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 14.5 pttt -42.52 -41.9 3.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.846 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.42 36.36 4.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.019 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 14.7 mmt-85 -145.17 -28.98 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.8 p -117.9 153.18 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 111.76 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE3' ' A' ' 26' ' ' LYS . 22.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.888 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.578 HD12 ' HA2' ' A' ' 51' ' ' GLY . 52.1 mt -105.68 114.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.864 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -127.57 163.28 24.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 111.508 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.877 ' HD2' HG11 ' A' ' 9' ' ' VAL . 9.7 ptmt -129.03 125.08 36.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.841 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 30' ' ' ILE . 11.4 p -115.59 162.04 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -109.71 149.12 30.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.2 2.38 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.773 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.533 HG21 ' HG3' ' A' ' 35' ' ' PRO . 25.8 p -64.9 -45.37 86.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -169.87 107.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.96 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER 174.15 -176.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.701 179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.132 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 75' ' ' VAL . 9.2 p 42.06 52.68 7.23 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.819 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 17' ' ' TYR . 37.4 Cg_endo -65.92 -26.1 51.84 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.482 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -56.34 175.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.09 140.73 31.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 84' ' ' THR . 4.1 mt -142.98 127.68 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.172 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -75.95 -29.56 58.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.466 0.65 . . . . 0.0 109.538 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -147.6 -81.84 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.2 m-85 -169.7 -60.51 0.0 OUTLIER Pre-proline 0 CA--C 1.472 -2.026 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.602 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.9 Cg_endo -41.8 72.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 121.434 1.423 . . . . 0.0 110.283 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -115.84 144.47 43.96 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 111.739 -2.482 . . . . 0.0 112.348 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 108' ' ' LEU . 11.9 mt -138.43 107.96 4.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.6 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.7 ttpm? -112.69 149.11 33.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.291 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 28' ' ' VAL . 3.4 tm? -130.8 119.22 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.479 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.35 105.03 19.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.0 126.07 13.98 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.443 2.095 . . . . 0.0 112.404 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 118' ' ' TYR . . . -60.19 129.46 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.28 -37.63 3.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.442 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.19 75.36 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.0 111.014 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.54 65.58 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.968 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.19 40.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.587 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 42.1 mm-40 -151.22 51.83 0.87 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 86.8 Cg_endo -77.94 132.56 11.83 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.711 HG11 ' CG ' ' A' ' 115' ' ' ASN . 26.7 m -84.78 152.75 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 107.61 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.979 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -87.92 132.83 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.835 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.5 m -73.24 -30.66 63.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 110.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.589 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.0 p -59.35 109.99 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.339 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -28.66 40.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -152.48 160.81 43.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.15 -49.73 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -48.58 -29.23 4.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -78.12 -34.5 49.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.815 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 HD13 ' A' ' 85' ' ' ILE . 13.5 mt -69.31 -30.78 68.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 112' ' ' ILE . 16.9 mt -73.37 -53.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -59.65 -22.98 62.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -72.77 -51.11 20.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -51.7 -47.28 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.035 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -77.19 -19.41 56.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.438 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.06 -52.23 9.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.711 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -90.69 -32.52 16.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.85 116.44 8.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.428 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -41.4 75.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.759 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -74.63 -16.56 60.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.944 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.21 50.38 0.77 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.938 0.399 . . . . 0.0 110.764 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . . . -64.29 78.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.035 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.068 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 3' ' ' LEU . 54.7 Cg_endo -69.69 -45.94 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.628 2.219 . . . . 0.0 112.284 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER -131.48 102.99 6.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.58 163.48 5.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 172.89 3.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.5 -36.53 5.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.51 65.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.0 -41.66 2.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.601 2.2 . . . . 0.0 112.367 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.79 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.6 t -115.77 139.03 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 94.7 m -73.42 143.42 46.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -103.67 129.6 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.411 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.893 HG23 ' CB ' ' A' ' 66' ' ' ALA . 40.5 t -113.66 112.45 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -121.02 162.29 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.707 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.94 -23.79 7.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.384 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -41.66 75.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.412 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -125.73 26.67 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.444 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HH ' ' HE2' ' A' ' 32' ' ' PHE . 5.9 t80 -69.79 -44.82 69.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.047 0.451 . . . . 0.0 110.576 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 8.3 m120 -69.97 -55.79 8.7 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.532 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.73 -36.95 38.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 111.716 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 16' ' ' ASN . 26.8 mm -73.3 -77.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.557 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -43.85 -31.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 111.371 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 24.0 mt -67.25 -39.87 86.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.213 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.41 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 111.401 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -84.39 -10.74 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.5 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -70.34 -22.1 62.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 111.199 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.24 164.35 27.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.891 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' HD11 ' A' ' 87' ' ' LEU . 5.4 t0 -81.45 130.73 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.863 ' O ' HD22 ' A' ' 87' ' ' LEU . 66.5 t -115.15 144.4 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.874 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -134.43 97.89 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.348 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 tt -101.26 137.65 28.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.935 0.398 . . . . 0.0 111.371 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 4.3 tm-20 -128.61 118.85 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.442 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.9 m-85 -95.03 142.71 27.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 0.0 111.059 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -156.41 164.55 38.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -107.25 139.75 20.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 71' ' ' THR . 54.8 Cg_endo -69.69 -10.1 27.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.484 2.122 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CZ2' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -102.39 -26.31 13.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.61 143.39 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.705 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.7 -26.42 53.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -23.46 18.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -65.95 -37.41 85.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.14 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -68.28 -40.55 81.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.932 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.86 71.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.28 1.02 41.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.372 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.689 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -67.56 -58.55 8.31 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.566 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.2 Cg_endo -71.61 -31.63 13.14 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.44 2.093 . . . . 0.0 112.673 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -68.6 -56.87 6.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.823 ' OH ' HD22 ' A' ' 29' ' ' LEU . 8.9 t80 -66.44 -30.36 70.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -37.18 76.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -66.69 -63.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.941 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.5 tm? -56.49 -30.38 62.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.011 0.434 . . . . 0.0 111.089 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -56.79 -64.01 4.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.956 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -65.81 -23.65 66.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -50.24 -68.2 0.19 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.307 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.662 ' HE2' HG23 ' A' ' 109' ' ' ILE . 22.9 m-85 -84.24 -31.45 24.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.522 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.679 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.97 -29.35 3.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.83 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -129.6 -27.25 2.39 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.7 t -79.64 -57.75 3.52 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.7 -59.95 1.7 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 45.8 m-85 -104.72 39.35 1.71 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 111.492 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -42.54 -36.65 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.853 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.52 27.15 9.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -147.31 8.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.2 p -148.35 149.01 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.44 105.55 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.874 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.0 mt -109.59 109.51 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.893 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -122.38 160.61 25.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.114 0.483 . . . . 0.0 111.622 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.79 ' CD ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -129.5 125.23 35.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.379 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 69' ' ' ASP . 12.9 p -125.42 160.52 31.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.551 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -96.33 149.18 21.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.203 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.86 1.19 54.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 35' ' ' PRO . 11.6 t -118.0 34.21 5.27 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.27 56.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.64 -178.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.237 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.61 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 1.4 t0 -54.37 -68.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.9 p 43.12 53.49 9.35 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 24.5 Cg_endo -61.7 -29.82 84.17 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.678 2.252 . . . . 0.0 112.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.41 144.28 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.667 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -84.01 142.78 30.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.808 HG23 HG21 ' A' ' 84' ' ' THR . 8.6 mm -138.61 147.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.487 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.93 -44.03 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -133.89 -89.11 0.35 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.0 m-85 -167.67 -60.54 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.629 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 1.2 Cg_endo -41.02 72.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.555 1.503 . . . . 0.0 110.352 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.934 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.5 p -116.18 148.36 40.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 111.771 -2.468 . . . . 0.0 112.125 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 108' ' ' LEU . 6.9 mt -138.68 107.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.322 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -110.33 150.25 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.452 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 28' ' ' VAL . 2.7 tm? -132.23 118.8 19.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.483 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -94.83 103.42 11.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.412 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 92' ' ' ALA . 35.0 Cg_endo -65.93 126.08 15.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.323 2.015 . . . . 0.0 112.363 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.12 124.37 15.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.93 -28.92 10.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.138 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . . . -112.63 83.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 50.02 1.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.54 21.03 0.2 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.773 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.62 ' N ' ' HD3' ' A' ' 96' ' ' PRO . 24.5 mm100 -146.35 52.31 1.43 Allowed Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.798 0.299 . . . . 0.0 111.189 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 95' ' ' GLN . 17.1 Cg_exo -66.05 132.48 30.14 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.313 2.009 . . . . 0.0 111.94 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 ' CG ' ' A' ' 115' ' ' ASN . 27.4 m -78.14 152.97 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.908 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.713 ' CE2' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -70.16 134.11 47.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -100.88 22.24 12.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.11 97.13 1.05 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.445 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -59.74 136.67 58.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.932 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -31.15 12.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 t -168.45 168.02 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -62.26 -48.42 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -53.66 -28.92 36.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -73.57 -36.81 65.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 85' ' ' ILE . 15.6 mt -68.22 -33.4 74.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.663 ' HA ' HD12 ' A' ' 112' ' ' ILE . 26.3 mt -70.96 -50.17 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -61.14 -24.12 66.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.004 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -72.82 -49.79 28.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.881 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 109' ' ' ILE . 5.7 mt -53.68 -43.37 54.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.217 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -78.79 -19.4 52.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.4 -52.08 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.081 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.724 ' CG ' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -91.46 -31.6 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.932 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.88 119.07 16.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.402 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -56.85 -41.34 77.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.44 -13.8 59.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.178 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.9 ttpp 66.67 51.47 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.6 77.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.052 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -36.75 68.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mt 60.35 174.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.28 46.69 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -124.0 95.27 4.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.08 168.65 9.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.58 61.39 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.479 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -41.53 3.28 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.566 2.177 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 48' ' ' GLU . 17.4 t -107.67 144.49 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 90.4 m -74.88 143.24 43.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.761 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.53 130.34 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.709 HG23 ' CB ' ' A' ' 66' ' ' ALA . 54.9 t -130.78 138.43 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -146.83 169.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.507 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.655 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -54.73 -23.01 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -70.89 -32.79 69.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.453 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -136.65 26.9 3.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.746 0.308 . . . . 0.0 111.397 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 13' ' ' VAL . 5.2 t80 -68.2 -45.15 74.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.706 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 4.9 m-80 -68.27 -55.75 11.04 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.615 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -36.42 30.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.917 0.389 . . . . 0.0 111.723 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 16' ' ' ASN . 23.6 mm -72.96 -78.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.586 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG1' ' CE1' ' A' ' 88' ' ' TYR . 40.1 t -43.89 -31.25 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.947 0.403 . . . . 0.0 111.446 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 26.7 mt -67.32 -39.67 85.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -45.35 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.949 0.404 . . . . 0.0 111.408 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -84.33 -10.72 57.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.579 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.8 p -70.23 -10.3 58.47 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -147.46 167.29 24.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 120' ' ' ALA . 8.6 m-20 -81.41 131.35 35.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.503 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' O ' HD22 ' A' ' 87' ' ' LEU . 94.7 t -115.53 141.12 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 111.368 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -136.77 97.82 3.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.537 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.52 HD11 ' CG1' ' A' ' 68' ' ' VAL . 11.7 tt -102.77 143.5 15.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 111.277 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.35 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.602 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.6 m-85 -94.57 141.32 28.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 40' ' ' CYS . 35.1 p90 -153.55 167.42 29.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -111.09 134.17 21.12 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.72 -14.87 45.47 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.421 2.081 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -103.48 -19.22 14.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.037 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 9.6 t -83.74 117.65 23.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.59 -21.21 41.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.744 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -29.06 38.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 111.14 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . 22.4 p -68.92 -34.15 74.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -65.69 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.86 -28.98 44.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.43 -1.44 35.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.458 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -69.1 -49.39 24.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.616 0.246 . . . . 0.0 111.549 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 3.1 Cg_exo -73.97 -51.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.72 2.28 . . . . 0.0 112.44 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 105' ' ' VAL . 1.5 mmpt? -58.45 -57.17 14.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.454 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.476 ' OH ' HD22 ' A' ' 29' ' ' LEU . 19.7 t80 -58.12 -36.16 72.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.206 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 9' ' ' VAL . 41.4 tt0 -67.01 -31.21 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.094 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -69.72 -63.12 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.92 -31.04 64.52 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 110.911 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.97 -64.31 4.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.026 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.56 66.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -50.99 -68.14 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.39 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.586 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.5 m-85 -84.31 -30.24 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 111.511 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.663 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.91 -30.29 4.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.722 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -129.49 -27.11 2.43 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.6 t -79.67 -57.94 3.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.82 -59.91 1.71 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 120' ' ' ALA . 3.8 m-85 -101.68 39.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.95 0.405 . . . . 0.0 111.278 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -42.37 -42.37 3.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.66 29.36 7.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -143.26 5.19 1.45 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 59' ' ' PHE . 4.6 p -152.2 152.97 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.992 0.425 . . . . 0.0 111.817 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 10' ' ' THR . 21.7 t -143.51 105.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.876 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.704 HG23 ' HB3' ' A' ' 29' ' ' LEU . 50.5 mt -105.43 107.63 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.709 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -116.88 166.26 12.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 111.566 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.18 125.14 27.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 30' ' ' ILE . 13.3 p -127.39 159.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.405 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -95.91 149.08 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.161 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . . . -87.78 1.18 54.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 10.7 t -117.98 34.42 5.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.14 56.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.2 p30 170.76 -177.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.189 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.655 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 t0 -54.67 -66.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.268 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 75' ' ' VAL . 8.3 p 43.47 53.25 9.55 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.7 -30.21 89.91 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.699 2.266 . . . . 0.0 112.278 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.53 146.11 36.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.762 ' O ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -83.94 145.36 28.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.932 HD12 HG21 ' A' ' 84' ' ' THR . 15.9 mm -143.57 145.42 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.827 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -76.03 -46.63 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.77 -86.96 0.47 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.936 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.9 m-85 -168.46 -59.97 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -1.981 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.0 Cg_endo -42.04 72.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.373 1.382 . . . . 0.0 110.257 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.936 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.6 p -115.9 148.44 40.0 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 111.721 -2.491 . . . . 0.0 112.054 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 84' ' ' THR . 5.6 mm -135.97 107.79 7.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.275 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 142.01 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.015 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 ' C ' HD13 ' A' ' 87' ' ' LEU . 2.5 tm? -124.32 114.57 19.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CE1' ' CG1' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -89.91 105.92 12.7 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.59 126.51 15.58 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.355 2.037 . . . . 0.0 112.317 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.93 115.87 5.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.69 -27.33 16.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.73 80.19 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.782 0.325 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -73.69 64.58 0.93 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.69 41.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.9 mm100 -155.2 53.25 0.81 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.327 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 56.3 Cg_endo -70.36 135.49 29.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.531 2.154 . . . . 0.0 112.266 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 115' ' ' ASN . 0.4 OUTLIER -77.98 136.39 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.86 14.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -80.24 117.34 20.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.5 p -69.95 -26.25 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.3 102.58 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.457 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.3 p -58.98 125.03 21.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -91.84 -31.85 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 t -160.88 176.33 11.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 109' ' ' ILE . 25.2 t -71.66 -44.21 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.871 ' HA ' HD12 ' A' ' 109' ' ' ILE . 5.0 pt-20 -54.02 -28.21 36.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.254 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.84 -41.51 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.005 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' CE2' ' A' ' 99' ' ' TYR . 13.0 mt -64.72 -31.52 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.049 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.871 HD12 ' HA ' ' A' ' 106' ' ' GLU . 6.0 mt -71.53 -57.59 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -24.99 56.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -70.61 -56.55 6.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.901 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 120' ' ' ALA . 5.3 mt -49.35 -38.26 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.487 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.016 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -82.23 -19.34 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.62 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -89.16 -30.19 18.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.855 0.36 . . . . 0.0 111.026 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.597 HD22 HG21 ' A' ' 97' ' ' VAL . 15.3 p30 -103.08 -37.03 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.475 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -61.8 123.94 32.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.64 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -59.43 -30.84 68.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -87.93 -7.57 56.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.228 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 62.43 53.2 2.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.709 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -64.39 79.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.245 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.033 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.26 160.47 3.35 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.32 77.26 7.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.16 46.66 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m -73.5 -50.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -108.5 42.14 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.46 52.76 0.71 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.54 -27.55 22.61 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.554 2.169 . . . . 0.0 112.356 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 67' ' ' LYS . 21.2 t -97.1 145.85 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 95.7 m -67.42 143.4 56.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.38 127.1 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.476 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' CB ' ' A' ' 66' ' ' ALA . 43.1 t -115.3 136.83 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG22 HD21 ' A' ' 16' ' ' ASN . 0.7 OUTLIER -141.65 165.33 18.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.907 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -52.0 -25.61 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 111.108 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -70.54 -39.73 73.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.547 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -123.82 30.26 6.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.079 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' VAL . 9.9 t80 -75.94 -42.8 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.058 0.456 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.526 ' C ' HD23 ' A' ' 22' ' ' LEU . 3.2 m120 -70.86 -54.96 9.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.221 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 20.5 mt-10 -54.44 -42.16 70.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.361 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 32.2 mm -75.06 -74.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG12 ' CE2' ' A' ' 88' ' ' TYR . 49.4 t -46.99 -48.46 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -72.83 -23.05 60.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -45.68 89.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.929 0.395 . . . . 0.0 111.297 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' LEU . 4.7 p30 -74.81 -10.71 59.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.576 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 74.7 p -70.25 -15.89 62.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.601 0.238 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 24.5 mttp -147.37 167.03 25.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -81.34 131.3 35.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.578 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 21' ' ' VAL . 59.2 t -119.6 147.4 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.554 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -136.64 97.85 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.196 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 68' ' ' VAL . 12.2 tt -102.75 141.58 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.537 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 7.9 tm-20 -128.54 113.49 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.418 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 5.7 m-85 -88.28 141.35 28.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.802 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 9.4 p90 -157.11 167.94 28.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.2 140.08 24.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.1 -8.58 23.99 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.437 2.091 . . . . 0.0 112.613 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -106.69 -19.38 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -76.05 136.14 39.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.752 0.31 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.1 -46.37 6.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.831 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -48.21 -31.39 5.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.956 0.407 . . . . 0.0 111.055 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.2 m -69.78 -32.58 71.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.905 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -29.71 70.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.84 -38.52 70.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.773 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -81.93 0.93 37.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.651 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -65.96 -57.64 13.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 57.9 Cg_endo -71.54 -26.2 20.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.455 2.104 . . . . 0.0 112.951 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HB2' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -75.35 -57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.232 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' HB2' HD22 ' A' ' 43' ' ' LEU . 43.4 t80 -67.12 -30.68 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.2 tt0 -70.04 -33.97 72.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -67.61 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.1 tm? -56.74 -30.95 64.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 110.984 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -56.15 -64.24 4.57 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.919 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -23.53 66.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.783 0.325 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.9 mt -49.81 -68.37 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HE2' HG23 ' A' ' 109' ' ' ILE . 21.3 m-30 -84.55 -31.89 24.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.644 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.612 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.85 -30.11 3.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.984 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 7.5 tttt -129.46 -27.14 2.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' LEU . 3.0 t -79.61 -57.59 3.61 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.69 -59.87 1.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.5 ' CB ' HG12 ' A' ' 63' ' ' VAL . 3.3 m-85 -104.11 39.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.7 -32.99 6.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.2 36.47 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 8.1 mtt180 -150.75 -35.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' CB ' ' A' ' 59' ' ' PHE . 9.7 p -115.13 154.91 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.925 0.393 . . . . 0.0 111.757 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.28 105.57 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 29' ' ' LEU . 35.8 mt -107.24 119.86 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.826 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -132.2 164.11 27.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.064 0.459 . . . . 0.0 111.4 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 9' ' ' VAL . 13.1 mtpp -128.65 125.04 37.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 30' ' ' ILE . 11.2 p -125.25 156.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -97.63 149.04 22.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.76 1.07 51.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.728 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 9.5 t -117.87 34.15 5.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . -179.36 55.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.3 p30 170.15 -177.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.18 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.597 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 9.2 t0 -55.78 -68.51 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.23 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.3 p 42.77 55.51 10.62 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 111.519 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 -26.6 49.39 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.65 2.234 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.5 148.8 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 79' ' ' ILE . 24.5 pt-20 -84.12 148.96 26.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.882 HD12 HG21 ' A' ' 84' ' ' THR . 18.6 mm -145.64 148.32 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.481 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -75.98 -46.78 27.82 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -132.59 -83.83 0.24 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.93 ' O ' ' N ' ' A' ' 84' ' ' THR . 4.4 m-85 -169.31 -59.83 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.971 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 3.1 Cg_endo -42.94 73.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 121.365 1.377 . . . . 0.0 110.115 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.93 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.7 p -116.37 148.48 40.59 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 111.752 -2.477 . . . . 0.0 112.133 -175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 84' ' ' THR . 8.6 mm -136.0 107.66 7.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.363 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.512 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.6 mmtt -105.9 146.59 29.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 115' ' ' ASN . 2.0 tm? -126.35 115.04 19.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.749 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' CE2' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -94.42 102.73 9.18 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.784 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 88' ' ' TYR . 40.5 Cg_endo -67.02 126.34 15.03 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.427 2.084 . . . . 0.0 112.33 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -66.99 115.86 7.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.8 -27.13 13.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -104.84 78.57 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -70.74 65.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.94 41.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.543 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.9 mm-40 -147.38 54.3 1.9 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 110.816 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 55.5 Cg_endo -69.96 119.46 6.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.326 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 111' ' ' PHE . 16.2 t -79.8 150.59 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 108.69 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.509 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -70.17 138.23 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.8 t -95.03 22.35 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.244 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.82 112.04 2.0 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.52 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.22 128.23 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' THR . 1.0 OUTLIER -109.08 -29.98 8.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 103' ' ' ARG . 1.4 t -161.61 168.66 23.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.831 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 t -75.72 -39.09 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' ILE . 6.3 pt-20 -55.13 -29.37 57.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -79.61 -36.66 37.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.6 -34.36 78.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.534 HG23 ' HE2' ' A' ' 54' ' ' TYR . 9.6 mt -72.62 -51.15 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.71 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -61.42 -21.87 64.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.874 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -71.84 -54.25 10.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 110.717 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.496 HD11 HD11 ' A' ' 29' ' ' LEU . 6.8 mt -51.63 -43.35 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.63 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.946 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -79.62 -19.35 49.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.57 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.34 -52.2 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.729 0.3 . . . . 0.0 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -89.77 -33.73 16.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.906 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' HA2' HD11 ' A' ' 87' ' ' LEU . . . -58.88 115.3 7.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.527 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.48 -36.64 66.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.66 -17.75 57.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.961 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 1.6 ttmt 68.06 48.5 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.721 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.423 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . . . -66.33 73.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.231 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.946 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.022 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.43 -61.89 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.3 110.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.78 -55.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 93.9 p -96.94 -177.14 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -146.02 102.7 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.89 57.25 0.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 -27.58 28.59 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.572 2.181 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 67' ' ' LYS . 14.8 t -88.57 153.14 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 66' ' ' ALA . 97.4 m -70.64 143.44 51.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.697 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -102.71 119.04 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.59 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.859 HG23 ' CB ' ' A' ' 66' ' ' ALA . 29.8 t -108.37 96.42 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 HD21 ' A' ' 16' ' ' ASN . 2.3 m -106.6 159.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.58 ' HB2' ' H ' ' A' ' 74' ' ' ASP . . . -47.66 -26.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.417 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -63.81 -45.54 89.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -126.23 28.55 6.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.833 0.349 . . . . 0.0 111.003 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 68' ' ' VAL . 2.3 t80 -67.07 -46.95 72.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.719 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -67.94 -56.38 9.23 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.407 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.85 -35.0 13.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.844 0.354 . . . . 0.0 111.861 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 16' ' ' ASN . 25.2 mm -74.39 -79.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.729 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 20' ' ' ILE . 38.7 t -43.93 -31.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.958 0.409 . . . . 0.0 111.537 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 36.5 mt -67.59 -42.67 82.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -45.5 91.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.888 0.375 . . . . 0.0 111.476 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -84.47 -10.86 57.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.512 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -70.25 -11.61 61.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 8.7 mtmm -140.25 165.59 26.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.831 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.34 125.49 30.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.509 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.848 ' O ' HD22 ' A' ' 87' ' ' LEU . 69.0 t -114.43 143.78 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.458 . . . . 0.0 111.32 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.902 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -135.91 97.81 3.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.225 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.846 HD11 HG11 ' A' ' 68' ' ' VAL . 4.9 tt -113.12 136.6 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 111.147 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -124.1 141.13 52.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.448 ' HB2' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -104.41 136.16 44.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 69' ' ' ASP . 3.3 p90 -156.93 168.54 27.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.112 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 36' ' ' TRP . . . -112.88 140.65 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.012 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 71' ' ' THR . 61.0 Cg_endo -72.74 -6.28 18.73 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.532 2.155 . . . . 0.0 112.644 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 3.4 p-90 -103.67 -22.71 13.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.175 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -71.38 141.06 50.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.95 -46.2 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.661 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -55.98 -26.57 48.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 111.016 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.8 m -75.68 -30.66 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -43.4 98.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.834 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.54 82.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 43' ' ' LEU . 2.7 tm? -75.47 -11.89 60.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.211 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.45 -56.95 16.25 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.649 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 21.6 Cg_endo -61.48 -38.78 60.74 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.437 2.091 . . . . 0.0 112.818 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.635 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.7 mmmt -62.86 -57.12 11.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.049 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.812 ' OH ' HD22 ' A' ' 29' ' ' LEU . 23.4 t80 -61.22 -25.81 67.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -71.33 -41.51 69.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 2.4 tm-20 -62.68 -62.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HA ' HD12 ' A' ' 53' ' ' LEU . 3.0 tm? -56.65 -30.87 63.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.988 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -53.57 -66.51 2.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.036 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -67.32 -23.71 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.713 0.292 . . . . 0.0 110.825 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -46.58 -68.89 0.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.803 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 121' ' ' ALA . 20.0 m-85 -84.75 -32.86 23.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.728 0.299 . . . . 0.0 111.594 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 60' ' ' LYS . . . -47.98 -29.07 3.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.83 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.625 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 1.7 pttt -128.91 -27.28 2.55 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 13.5 m -79.99 -58.31 3.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -97.21 -59.92 1.69 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 62' ' ' ARG . 3.3 m-85 -98.35 38.96 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.149 0.499 . . . . 0.0 110.84 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -42.64 -44.79 4.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.957 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -118.46 36.44 4.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.07 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -143.53 -28.79 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 59' ' ' PHE . 5.6 p -117.65 154.32 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 111.881 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.48 105.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.709 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.676 HG23 ' HB3' ' A' ' 29' ' ' LEU . 33.6 mt -106.95 116.29 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.138 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.859 ' CB ' HG23 ' A' ' 12' ' ' VAL . . . -126.9 159.8 32.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.245 0.545 . . . . 0.0 111.727 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' HG3' HG11 ' A' ' 9' ' ' VAL . 1.4 mtmt -121.34 125.0 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.846 HG11 HD11 ' A' ' 30' ' ' ILE . 11.7 p -123.51 143.42 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 111.435 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.5 OUTLIER -99.21 142.9 30.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.295 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.15 29.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.794 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 35' ' ' PRO . 9.8 t -117.89 34.59 5.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -177.93 48.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 69' ' ' ASP . 1.4 p30 170.74 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 111.346 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.58 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 30.4 t0 -55.9 -61.12 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 75' ' ' VAL . 7.2 p 43.22 57.51 12.06 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.457 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.98 -32.55 76.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -57.22 139.58 52.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 79' ' ' ILE . 5.8 pt-20 -84.02 145.43 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 84' ' ' THR . 6.1 mm -141.29 146.38 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.408 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.84 -45.43 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG ' ' A' ' 82' ' ' PHE . . . -129.35 -92.3 0.67 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.933 ' O ' ' N ' ' A' ' 84' ' ' THR . 3.5 m-85 -167.8 -60.41 0.01 OUTLIER Pre-proline 0 CA--C 1.473 -2.014 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.615 ' CD ' ' HB2' ' A' ' 82' ' ' PHE . 2.3 Cg_endo -41.98 73.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.755 0 C-N-CA 121.324 1.349 . . . . 0.0 110.255 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.933 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.4 p -118.89 148.26 43.11 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 111.696 -2.502 . . . . 0.0 111.951 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.562 HG21 HD22 ' A' ' 108' ' ' LEU . 2.8 mm -140.35 107.74 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.006 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 29' ' ' LEU . 6.4 mtmm -110.3 146.97 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.902 HD23 ' HG ' ' A' ' 29' ' ' LEU . 3.0 tm? -126.54 122.71 35.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.508 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -96.43 106.26 28.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.555 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 121.23 8.54 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.366 2.044 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 26' ' ' LYS . . . -59.72 124.87 21.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.53 -28.71 12.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 117' ' ' LYS . . . -105.21 74.68 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.074 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 64.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.15 37.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 28.2 mm100 -155.21 50.97 0.55 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 111.055 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 95' ' ' GLN . 88.8 Cg_endo -78.15 130.21 10.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.503 2.135 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.9 m -82.63 152.29 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.7 m -126.06 121.56 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CE2' ' CD2' ' A' ' 111' ' ' PHE . 0.1 OUTLIER -96.58 138.15 34.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 p -95.64 22.35 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.81 99.39 2.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.692 ' OG ' HD21 ' A' ' 108' ' ' LEU . 1.1 m -66.31 156.19 35.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -30.17 8.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 107' ' ' ASP . 1.8 t -144.89 172.9 12.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 109' ' ' ILE . 21.8 t -80.09 -40.74 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.747 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.7 pt-20 -56.32 -29.94 61.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB2' HG23 ' A' ' 104' ' ' THR . 3.3 t0 -76.7 -40.05 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD21 ' OG ' ' A' ' 102' ' ' SER . 18.5 mt -65.79 -34.46 78.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.845 ' HA ' HD12 ' A' ' 112' ' ' ILE . 7.3 mt -70.25 -53.21 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -57.17 -25.13 58.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.435 ' CD2' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -73.08 -45.23 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.3 mt -55.05 -45.7 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . . . -76.83 -21.35 55.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.14 -48.16 13.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.548 ' OD1' HD12 ' A' ' 87' ' ' LEU . 20.1 p30 -91.88 -35.43 14.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 121.64 27.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 92' ' ' ALA . 14.1 tttt -58.47 -41.13 84.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.848 0.356 . . . . 0.0 110.916 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.97 -9.37 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.224 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mttp 62.85 54.45 2.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.404 . . . . 0.0 110.783 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -65.76 78.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.237 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.054 179.827 . . . . . . . . 1 1 . 1 stop_ save_